HAP Trading’s GoodRx Holdings GDRX Stock Holding History

HAP Trading’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,625	Closed	-$422K	–	2538
2021 Q2	$419K	Buy	+11,625	New	+$429K	0.01%	712

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

HAP Trading's GDRX Position: Q3 2021 in Review

HAP Trading sold out of GoodRx Holdings (GDRX) in Q3 2021, closing a stake of 11,625 shares — an estimated $422K sold.

HAP Trading first reported a position in GDRX in Q2 2021 and held it in 1 quarter. The position peaked at $419K in Q2 2021. 218 funds tracked by Wall St. Rank hold GDRX as of Q3 2021.

HAP Trading reported no remaining GoodRx Holdings position as of Q3 2021 after selling out during the quarter.
HAP Trading sold 11,625 GoodRx Holdings shares in Q3 2021, an estimated $422K.
HAP Trading first reported a position in GoodRx Holdings in Q2 2021 and held it in 1 quarter.
HAP Trading's GoodRx Holdings position peaked at $419K in Q2 2021.
218 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2021.

Based on HAP Trading's 13F filing for Q3 2021, filed 10 Nov 2021.